StonvexLoading…
StonvexStonvexStonvexCore line items from LIVN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.39B | $1.25B | $1.15B | $1.02B |
Operating Income | $199.39M | $129.05M | $-68.50M | $-76.75M |
Net Income | $-242.47M | $63.23M | $17.55M | $-86.25M |
EPS (Diluted) | $-4.45 | $1.16 | $0.32 | $-1.61 |
Total Assets | $2.61B | $2.51B | $2.43B | $2.29B |
Total Liabilities | $1.41B | $1.19B | $1.15B | $1.09B |
Cash & Equivalents | $635.55M | $428.86M | $266.50M | $214.17M |
Free Cash Flow OCF − CapEx | $173.29M | $135.93M | $39.93M | $43.40M |
Shares Outstanding | 54.65M | 54.35M | 53.92M | 53.56M |